Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I/IIa clinical trial
- Author
- SENTI, G1 2 ; JOHANSEN, P1 ; KÜNDIG, T. M1 ; HAUG, S1 ; BULL, C1 ; GOTTSCHALLER, C1 ; MÜLLER, P3 ; PFISTER, T3 ; MAURER, P3 ; BACHMANN, M. F3 ; GRAF, N2
[1] Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
[2] Center for Clinical Research, University Hospital Zurich, Zurich, Switzerland
[3] Cytos Biotechnology AG, Schlieren, Switzerland - Source
Clinical and experimental allergy (Print). 2009, Vol 39, Num 4, pp 562-570, 9 p ; ref : 52 ref
- ISSN
- 0954-7894
- Scientific domain
- Dermatology; Immunology, immunopathology, allergology; Pneumology
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Type A CpG allergy house dust mite specific immunotherapy virus-like particles
- Keyword (fr)
- Acarien Allergie Désensibilisation Essai clinique phase I Homme Immunologie Immunothérapie Oligodésoxyribonucléotide Particule type viral Poussière maison Séquence nucléotide Séquence riche GC Traitement adjuvant Utilisation Immunopathologie
- Keyword (en)
- Mite Allergy Desensitization Phase I trial Human Immunology Immunotherapy Oligodeoxyribonucleotide Virus like particle House dust Nucleotide sequence GC rich sequence Adjuvant treatment Use Immunopathology
- Keyword (es)
- Acaro Alergia Desensibilización Ensayo clínico fase I Hombre Inmunología Inmunoterapia Oligodesoxirribonucleótido Partícula tipo vírico Polvo casa Secuencia nucleótido Secuencia rica GC Tratamiento adyuvante Uso Inmunopatología
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A06 Fundamental immunology
- Discipline
- Fundamental immunology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21236628
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1365-2222.2008.03191.x 
https://dx.doi.org/10.1111/j.1365-2222.2008.03191.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2222.2008.03191.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical and experimental allergy (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Clin. exp. allergy (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"562\";s:8:\"\u0000*\u0000epage\";s:3:\"570\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0954-7894\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SENTI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:11:\"JOHANSEN, P\";i:1;s:13:\"K\u00dcNDIG, T. M\";i:2;s:7:\"HAUG, S\";i:3;s:7:\"BULL, C\";i:4;s:15:\"GOTTSCHALLER, C\";i:5;s:10:\"M\u00dcLLER, P\";i:6;s:10:\"PFISTER, T\";i:7;s:9:\"MAURER, P\";i:8;s:14:\"BACHMANN, M. F\";i:9;s:7:\"GRAF, N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2222.2008.03191.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical and experimental allergy (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Clin. exp. allergy (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"562\";s:8:\"\u0000*\u0000epage\";s:3:\"570\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0954-7894\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SENTI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:11:\"JOHANSEN, P\";i:1;s:13:\"K\u00dcNDIG, T. M\";i:2;s:7:\"HAUG, S\";i:3;s:7:\"BULL, C\";i:4;s:15:\"GOTTSCHALLER, C\";i:5;s:10:\"M\u00dcLLER, P\";i:6;s:10:\"PFISTER, T\";i:7;s:9:\"MAURER, P\";i:8;s:14:\"BACHMANN, M. F\";i:9;s:7:\"GRAF, N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2222.2008.03191.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2222.2008.03191.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical and experimental allergy (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Clin. exp. allergy (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"562\";s:8:\"\u0000*\u0000epage\";s:3:\"570\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0954-7894\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SENTI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:11:\"JOHANSEN, P\";i:1;s:13:\"K\u00dcNDIG, T. M\";i:2;s:7:\"HAUG, S\";i:3;s:7:\"BULL, C\";i:4;s:15:\"GOTTSCHALLER, C\";i:5;s:10:\"M\u00dcLLER, P\";i:6;s:10:\"PFISTER, T\";i:7;s:9:\"MAURER, P\";i:8;s:14:\"BACHMANN, M. F\";i:9;s:7:\"GRAF, N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2222.2008.03191.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical and experimental allergy (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Clin. exp. allergy (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"562\";s:8:\"\u0000*\u0000epage\";s:3:\"570\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0954-7894\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SENTI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:11:\"JOHANSEN, P\";i:1;s:13:\"K\u00dcNDIG, T. M\";i:2;s:7:\"HAUG, S\";i:3;s:7:\"BULL, C\";i:4;s:15:\"GOTTSCHALLER, C\";i:5;s:10:\"M\u00dcLLER, P\";i:6;s:10:\"PFISTER, T\";i:7;s:9:\"MAURER, P\";i:8;s:14:\"BACHMANN, M. F\";i:9;s:7:\"GRAF, N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2222.2008.03191.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Clinical and experimental allergy (Print)\";s:9:\"\u0000*\u0000stitle\";s:26:\"Clin. exp. allergy (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"562\";s:8:\"\u0000*\u0000epage\";s:3:\"570\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0954-7894\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SENTI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:11:\"JOHANSEN, P\";i:1;s:13:\"K\u00dcNDIG, T. M\";i:2;s:7:\"HAUG, S\";i:3;s:7:\"BULL, C\";i:4;s:15:\"GOTTSCHALLER, C\";i:5;s:10:\"M\u00dcLLER, P\";i:6;s:10:\"PFISTER, T\";i:7;s:9:\"MAURER, P\";i:8;s:14:\"BACHMANN, M. F\";i:9;s:7:\"GRAF, N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans : a phase I\/IIa clinical trial\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
